Sun BioPharma, Inc. Business Finance Contracts & Agreements
90 Contracts & Agreements
- Exchange Agreements (1 contract)
- Guaranty Agreements (1)
- Investment Agreements (2)
- Loan Agreements (5)
- Note Agreements (10)
- Participation Agreements (1)
- Purchase Agreements (14)
- Security Agreements (1)
- Stock Agreements (2)
- Subordination Agreement (2)
- Underwriting Agreements (5)
- Waiver Agreements (2)
- Warrant Agreements (44)
- Senior Convertible Promissory Tranche B Note issued to Nant Capital, LLC, dated November 15, 2024 (Filed With SEC on November 18, 2024)
- Subordination Agreement, dated as of August 19, 2024 (Filed With SEC on November 14, 2024)
- Subordinated Promissory Note, dated as of August 19, 2024 (Filed With SEC on November 14, 2024)
- Waiver, by and among Panbela Therapeutics, Inc., Cancer Prevention, Pharmaceuticals, LLC and USWM, LLC. dated October 2, 2024 (Filed With SEC on November 14, 2024)
- Continuing Guaranty Agreement, dated October 22, 2024, made by Cancer Prevention Pharmaceuticals, Inc. and Panbela Research, Inc., in favor of Nant Capital, LLC (Filed With SEC on October 28, 2024)
- Senior Convertible Promissory Tranche A Note issued to Nant Capital, LLC, dated October 22, 2024 (Filed With SEC on October 28, 2024)
- Note Purchase Agreement, dated October 22, 2024, between Nant Capital, LLC, as Investor, and Panbela Therapeutics, Inc., as Company (Filed With SEC on October 28, 2024)
- Subordination Agreement, dated as of August 8, 2024 (Filed With SEC on August 13, 2024)
- Subordinated Promissory Note, dated as of August 8, 2024 (Filed With SEC on August 13, 2024)
- Waiver by and among Panbela Therapeutics, Inc., Cancer Prevention, Pharmaceuticals, LLC and USWM, LLC, dated August 8, 2024 (Filed With SEC on August 13, 2024)
- Security Agreement, dated July 24, 2024, made by Panbela Therapeutics, Inc. and Cancer Prevention Pharmaceuticals, Inc. in favor of USWM, LLC (Filed With SEC on July 30, 2024)
- Term Promissory Note issued to USWM, LLC, dated July 24, 2024 (Filed With SEC on July 30, 2024)
- Loan Agreement, dated July 24, 2024, by and among USWM, LLC, as lender, and Panbela Therapeutics, Inc. and Cancer Prevention Pharmaceuticals, Inc., as borrowers (Filed With SEC on July 30, 2024)
- Subscription and Investment Representation Agreement, dated April 23, 2024, by and between Panbela Therapeutics, Inc. and Michael T. Cullen (Filed With SEC on April 25, 2024)
- Form of Securities Purchase Agreement dated as of January 28, 2024 by and between Panbela Therapeutics, Inc. and the purchasers named therein (Filed With SEC on January 29, 2024)
- Form of Class F Common Stock Purchase Warrant (Filed With SEC on January 29, 2024)
- Form of Class E Common Stock Purchase Warrant (Filed With SEC on January 29, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on January 25, 2024)
- Form of Class E Common Stock Purchase Warrant (Filed With SEC on January 25, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on January 4, 2024)
- CLASS F COMMON STOCK PURCHASE WARRANT PANBELA THERAPEUTICS, INC. (Filed With SEC on January 4, 2024)
- Form of Class F Common Stock Purchase Warrant (Filed With SEC on January 4, 2024)
- Form of Class E Common Stock Purchase Warrant (Filed With SEC on January 4, 2024)
- Form of Warrant Agency Agreement with VStock Transfer, LLC (Filed With SEC on January 4, 2024)
- Form of Inducement Warrant (Filed With SEC on December 21, 2023)
- Form of Inducement Warrant (Filed With SEC on November 3, 2023)
- Form of Securities Purchase Agreement by and between Panbela Therapeutics, Inc. and the purchasers named therein (Filed With SEC on June 21, 2023)
- Form of Class B Common Stock Purchase Warrant (Filed With SEC on June 21, 2023)
- Form of Class A Common Stock Purchase Warrant (Filed With SEC on June 21, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on June 21, 2023)
- Warrant Agency Agreement dated as of June 21, 2023 by and between Panbela Therapeutics, Inc. and VStock Transfer, LLC (Filed With SEC on June 21, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on June 2, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on June 2, 2023)
- Form of Class B Common Stock Purchase Warrant (Filed With SEC on June 2, 2023)
- Form of Class A Common Stock Purchase Warrant (Filed With SEC on June 2, 2023)
- Form of Warrant Agency Agreement (Filed With SEC on June 2, 2023)
- Subscription and Investment Representation Agreement, dated April 14, 2023, by and between Panbela Therapeutics, Inc. and Michael T. Cullen (Filed With SEC on April 18, 2023)
- Form of Securities Purchase Agreement by and between Panbela Therapeutics, Inc. and the purchasers named therein (Filed With SEC on January 31, 2023)
- Form of Common Stock Purchase Warrant (Filed With SEC on January 31, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on January 31, 2023)
